ALPL

ALPL 詳細

英語名Alkaline phosphatase, tissue-nonspecific isozyme市販薬剤の数1
治験薬の数3ターゲットの別称Alkaline Phosphatase, Biomineralization Associated,EC:3.1.3.1,Alkaline Phosphatase Liver/Bone/Kidney Isozyme,Liver/Bone/Kidney-Type Alkaline Phosphatase,ALPL,AP-TNAP,Alkaline Phosphatase, Liver/Bone/Kidney,Tissue Non-Specific Alkaline Phosphatase,TNSALP,Alkaline Phosphatase, Tissue-Nonspecific Isozyme,Tissue-Nonspecific ALP,EC 3.1.3.1,APTNAP,TNALP,TNAP,HOPS
研究&開発段階Approved
英語名Alkaline phosphatase, tissue-nonspecific isozyme
ターゲットの別称Alkaline Phosphatase, Biomineralization Associated,EC:3.1.3.1,Alkaline Phosphatase Liver/Bone/Kidney Isozyme,Liver/Bone/Kidney-Type Alkaline Phosphatase,ALPL,AP-TNAP,Alkaline Phosphatase, Liver/Bone/Kidney,Tissue Non-Specific Alkaline Phosphatase,TNSALP,Alkaline Phosphatase, Tissue-Nonspecific Isozyme,Tissue-Nonspecific ALP,EC 3.1.3.1,APTNAP,TNALP,TNAP,HOPS
市販薬剤の数1
治験薬の数3
研究&開発段階Approved

ALPL 製品リスト

  • 属性

    Protein (4)

  • 製品ライブラリ

    オンライン (4)

  • Human (2)Mouse (1)Cynomolgus (1)

  • タグ

    His Tag (4)

  • マーカー

    Unconjugated (3)HRP Labeled (1)

ALPLバックグランド

This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects.

ALPL分子の別称

AP-TNAP, APTNAP, HOPS, HPPA, HPPC, HPPI, HPPO, TNALP, TNAP, TNS-ALP, TNSALP

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
ALXN-1850ALXN-1850Phase 3 ClinicalAlexion Pharmaceuticals IncHypophosphatasia
詳細
DS-1211DS-1211Phase 2 ClinicalDaiichi Sankyo Co Ltd, Sanford Burnham Prebys Medical Discovery InstituteOssification, Heterotopic; Pseudoxanthoma Elasticum
詳細
ALXN-1910ALXN-1910Phase 1 ClinicalAlexion Pharmaceuticals Inc
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Asfotase alfasTNALP-FcD10; ALXN-1215; sALP-FcD10; ENB-0040ApprovedAlexion Pharmaceuticals IncStrensiqJapanHypophosphatasiaAlexion Pharmaceuticals Inc2015-07-03Hypophosphatasia
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8